Home > bioMérieux - First-Half 2011 Business Review
bioMérieux - First-Half 2011 Business Review
19 July, 2011
bioMerieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2011.
At constant exchange rates and comparable business base*
First-half sales up 4.3%
Second-quarter sales accelerate: up 5.1%
Good performance in North America confirmed: up 5.1%
Strong increase in China: up 35%
Two strategic acquisitions during the period
Confirmation of the 2011 objective for sales growth
Jean-Luc Belingard, Chairman of the Board, takes on the role of CEO, heading the Management Committee, and Stephane Bancel joins Institut Merieux as Senior Advisor